Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.43 |
| ▸ | CTSC | P53634 | 3/20 | 0.40 |
| ▸ | PRCP | P42785 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30910373 | 1.00 | KMT2A (0.46) | KMT2AMEN1DPP7CTSCPRCP | |
| SCHEMBL29608142 | 0.96 | MEN1 (0.44) | KMT2AMEN1DPP7CTSC | |
| SCHEMBL29630484 | 0.95 | KMT2A (0.43) | KMT2AMEN1DPP7CTSC | |
| SCHEMBL5970810 | 0.95 | KMT2A (0.49) | KMT2AMEN1DPP7CTSCPRCP | |
| SCHEMBL21647349 | 0.95 | KMT2A (0.49) | KMT2AMEN1DPP7CTSCPRCP | |
| SCHEMBL5970814 | 0.95 | KMT2A (0.49) | KMT2AMEN1DPP7CTSCPRCP | |
| SCHEMBL29630350 | 0.94 | MEN1 (0.41) | KMT2AMEN1DPP7CTSCPRCP | |
| SCHEMBL30193330 | 0.93 | MEN1 (0.41) | KMT2AMEN1DPP7CTSC | |
| SCHEMBL31721038 | 0.91 | MEN1 (0.42) | KMT2AMEN1DPP7 | |
| SCHEMBL30930183 | 0.91 | MEN1 (0.42) | KMT2AMEN1DPP7CTSCPRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |